GLENMARK THERAPEUTICS Trademark

Trademark Overview

On Monday, April 4, 2022, a trademark application was filed for GLENMARK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GLENMARK THERAPEUTICS trademark a serial number of 97345580. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by Glenmark Therapeutics Inc., USA. The GLENMARK THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

House mark for pharmaceutical preparations and chemical preparations for pharmaceutical or medical purposes
glenmark therapeutics

General Information

Serial Number97345580
Word MarkGLENMARK THERAPEUTICS
Filing DateMonday, April 4, 2022
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7444160
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Goods and ServicesHouse mark for pharmaceutical preparations and chemical preparations for pharmaceutical or medical purposes
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateWednesday, July 6, 2022
First Use In Commerce DateMonday, August 1, 2022

Trademark Owner History

Party NameGlenmark Therapeutics Inc., USA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430
Party NameGlenmark Therapeutics Inc., USA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430
Party NameGlenmark Therapeutics Inc., USA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430

Trademark Events

Event DateEvent Description
Thursday, April 7, 2022NEW APPLICATION ENTERED
Friday, April 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 11, 2022ASSIGNED TO EXAMINER
Thursday, May 12, 2022NON-FINAL ACTION WRITTEN
Thursday, May 12, 2022NON-FINAL ACTION E-MAILED
Thursday, May 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 18, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, January 18, 2023USE AMENDMENT FILED
Thursday, February 16, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 27, 2023NON-FINAL ACTION E-MAILED
Monday, March 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 27, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, May 3, 2023TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, May 3, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 3, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, May 3, 2023SOU EXTENSION 1 FILED
Thursday, May 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 18, 2023DIVISIONAL PROCESSING COMPLETE
Monday, September 18, 2023SOU EXTENSION 1 GRANTED
Tuesday, September 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 24, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 24, 2024ITU LETTER MAILED, NO RESPONSE REQUIRED
Wednesday, January 31, 2024SU - FINAL REFUSAL - WRITTEN
Wednesday, January 31, 2024FINAL REFUSAL E-MAILED
Wednesday, January 31, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, March 18, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 29, 2024SU - ACTION CONTINUING FINAL - WRITTEN
Monday, April 29, 2024CONTINUATION OF FINAL REFUSAL E-MAILED
Monday, April 29, 2024NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Tuesday, April 30, 2024EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, April 30, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, April 30, 2024EX PARTE APPEAL-INSTITUTED
Tuesday, June 4, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 4, 2024EXPARTE APPEAL TERMINATED
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 4, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 27, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED

Related Keywords

therapeutics glenmark pharmaceutical preparations purposes medical chemical house mark